<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55525">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02149732</url>
  </required_header>
  <id_info>
    <org_study_id>COMET trial</org_study_id>
    <secondary_id>MKKim</secondary_id>
    <nct_id>NCT02149732</nct_id>
  </id_info>
  <brief_title>Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation</brief_title>
  <official_title>An Investigator-initiated Trial (IIT) on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation in Corneal Limbal Deficiency Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health &amp; Welfare, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effect of ocular surface reconstruction and assess the safety in
      cultivated oral mucosal epithelial cell sheet transplantation (COMET) regarding patients
      with cicatricial change of ocular surface.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional study for treatment of patients with cicatricial change of ocular surface.

      Single Group: (Limbal stem cell deficiency group)

      Treatment: After cultivating autologous Oral mucosal epithelial cell sheet, the sheet will
      be transplanted to the ocular surface of the patients

      Inclusion criteria

        1. patient with eye which has limbal stem cell deficiency and conjunctivalization of
           cornea

        2. patient who shows no improvement after limbal tissue or amniotic membrane
           transplantation, or who has difficulty in receiving long-term immunosuppressive
           treatment

        3. patient who agree this clinical trial

        4. patient with the eyes in which best corrected visual acuity is less than counting
           finger

        5. patient who is older than sixteen year old

      Exclusion criteria

        1. patient who has relevant corneal transparency

        2. patient who is on the pregnancy or has a plan of pregnancy within 1 year

        3. patient who has corneal infection

        4. patient who has diagnosis of HBV, HCV, HIV, syphilis

        5. patinet who has past medial history of antinal, myocardial infarction, heart failure,
           arrhythmia, brain stroke, cerebrovascular disease

        6. patient who has malignancy

        7. patient who shows hypersensitivity to bovine protein.

      Primary outcome Epithelization of corneal surface (6 months after cell sheet
      transplantation)

      Secondary outcome Visual acuity (6 months after cell sheet transplantation)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Epithelization of corneal surface</measure>
    <time_frame>6 months after cell sheet transplantation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Epithelization area in total corneal surface (%)
= Epithelized corneal surface area / Total corneal surface area x 100 (%)
Corneal diameter = R Diameter in non-epithelized area = r Epithelized corneal surface area = 3.14x(R2-r2)/4 Total corneal surface area = 3.14xR2/4</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best Corrected Visual Acuity (BCVA)</measure>
    <time_frame>6 months after cell sheet transplantation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Best Corrected Visual Acuity (BCVA) will be converted logMAR scale for the statistical analysis.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>CBC</measure>
    <time_frame>1 week, 1 months, 3 months, 6 months after cell sheet transplantataion</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Liver function test</measure>
    <time_frame>1 week, 1 months, 3 months, 6 months after cell sheet transplantataion</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Renal function test</measure>
    <time_frame>1 week, 1 months, 3 months, 6 months after cell sheet transplantataion</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Serum electrolyte</measure>
    <time_frame>1 week, 1 months, 3 months, 6 months after cell sheet transplantataion</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Vital sign</measure>
    <time_frame>1 week, 1 months, 3 months, 6 months after cell sheet transplantataion</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Limbal Stem Cell Deficiency</condition>
  <condition>Cultivated Oral Mucosal Cell Sheet Transplantation</condition>
  <condition>Ocular Surface Reconstruction</condition>
  <arm_group>
    <arm_group_label>COMET group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cultivated autologous oral mucosal epithelial cell sheet transplantation group</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous oral mucosal epithelial cell sheet transplantation</intervention_name>
    <arm_group_label>COMET group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patient with eye which has limbal stem cell deficiency and conjunctivalization of
             cornea

          2. patient who shows no improvement after limbal tissue or amniotic membrane
             transplantation, or who has difficulty in receiving long-term immunosuppressive
             treatment

          3. patient who agree this clinical trial

          4. patient with the eyes in which best corrected visual acuity is less than counting
             finger

          5. patient who is older than sixteen year old

        Exclusion Criteria:

          1. patient who has relevant corneal transparency

          2. patient who is on the pregnancy or has a plan of pregnancy within 1 year

          3. patient who has corneal infection

          4. patient who has diagnosis of HBV, HCV, HIV, syphilis

          5. patinet who has past medial history of antinal, myocardial infarction, heart failure,
             arrhythmia, brain stroke, cerebrovascular disease

          6. patient who has malignancy

          7. patient who shows hypersensitivity to bovine protein.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mee Kum Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, Seoul National University College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mee Kum Kim, MD, PhD</last_name>
    <phone>82-10-6277-0798</phone>
    <email>kmk9@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dong Hyun Kim, MD</last_name>
    <phone>82-10-3737-0975</phone>
    <email>amidfree@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National Unversity Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mee Kum Kim, MD, PhD</last_name>
      <phone>82-10-6277-0798</phone>
      <email>kmk9@snu.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mee Kum Kim, MD, PhD</last_name>
      <phone>82-10-6277-0798</phone>
      <email>kmk9@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Dong Hyun Kim, MD</last_name>
      <phone>82-10-3737-0975</phone>
      <email>amidfree@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mee Kum Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Nishida K, Yamato M, Hayashida Y, Watanabe K, Yamamoto K, Adachi E, Nagai S, Kikuchi A, Maeda N, Watanabe H, Okano T, Tano Y. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med. 2004 Sep 16;351(12):1187-96.</citation>
    <PMID>15371576</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 25, 2014</lastchanged_date>
  <firstreceived_date>May 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Limbal stem cell deficiency</keyword>
  <keyword>Cultivated oral mucosal cell sheet transplantation</keyword>
  <keyword>Ocular surface reconstruction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
